MapLight Therapeutics (NAS: MPLT)

Burlington, MA · Founded 2018 · Publicly Held

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. MapLight Therapeutics (NAS: MPLT) is based in Burlington, MA and was founded in 2018. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $704 million (Oct 2025). It has raised $919 million.

Last price · $/share

—

Implied valuation

$704.3M

Total raised

$919.4M

Last round

—

Who backs MapLight Therapeutics (NAS: MPLT)?

2 investors

Investor	Type
Novo Holdings	Other
The Goldman Sachs Group	—

The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MapLight Therapeutics (NAS: MPLT) investors

2 investors are on record for MapLight Therapeutics (NAS: MPLT), including Novo Holdings and The Goldman Sachs Group.

Free account

More of MapLight Therapeutics (NAS: MPLT) with a free account

·Watch MapLight Therapeutics (NAS: MPLT): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

For fundraisers

Work this list, don’t just read it

These 2 firms already write checks for companies like MapLight Therapeutics (NAS: MPLT). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View